D-0007-2025 Class II Ongoing
FDA drug recall D-0007-2025 was initiated by Advanced Accelerator Applications USA, Inc. on Sep 23, 2024 and is designated Class II. Reason for recall: CGMP deviations The recall status is ongoing. Affected quantity: 99 doses.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 9, 2024
- Initiation Date
- Sep 23, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 99 doses
Product description
Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications, 57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61
Reason for recall
CGMP deviations
Distribution pattern
FL, MA, NJ, NY, PA, and VA
Code information
Lot#: LPS240919B-16, 24-Sep-2024 Lot#: LPS240920B-16, 25-Sep-2024 Lot#: LPS240920C-16, 25-Sep-2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0007-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026